HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bohuslav Melichar Selected Research

human MIRN-4443 microRNA

1/2021Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bohuslav Melichar Research Topics

Disease

83Neoplasms (Cancer)
10/2022 - 07/2002
51Renal Cell Carcinoma (Grawitz Tumor)
10/2022 - 07/2005
39Breast Neoplasms (Breast Cancer)
10/2021 - 01/2006
27Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 07/2002
20Carcinoma (Carcinomatosis)
01/2021 - 07/2002
17Neoplasm Metastasis (Metastasis)
09/2017 - 10/2002
12Disease Progression
10/2022 - 01/2011
11Adenocarcinoma
04/2022 - 08/2006
11Hypertension (High Blood Pressure)
01/2021 - 02/2013
10Kidney Neoplasms (Kidney Cancer)
10/2022 - 11/2013
8Pancreatic Neoplasms (Pancreatic Cancer)
10/2022 - 04/2003
8Diarrhea
10/2021 - 11/2006
7Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 03/2007
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 11/2006
6Ovarian Epithelial Carcinoma
01/2022 - 09/2003
6Esophageal Neoplasms (Esophageal Cancer)
01/2019 - 01/2017
5Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2020 - 11/2005
4Prostatic Neoplasms (Prostate Cancer)
10/2021 - 12/2019
4Peritoneal Neoplasms
09/2020 - 11/2003
4Fatigue
10/2019 - 12/2007
4Brain Neoplasms (Brain Tumor)
12/2016 - 08/2004
4Atherosclerosis
02/2016 - 11/2009
3Squamous Cell Carcinoma of Head and Neck
01/2021 - 04/2015
3Stomach Neoplasms (Stomach Cancer)
12/2018 - 07/2004
3Melanoma (Melanoma, Malignant)
12/2018 - 11/2015
3Inflammation (Inflammations)
12/2018 - 12/2016
3Neutropenia
09/2016 - 02/2013
2Hyperbilirubinemia
02/2022 - 01/2012

Drug/Important Bio-Agent (IBA)

19Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2013
18Sunitinib (Sutent)FDA Link
10/2022 - 12/2012
17Bevacizumab (Avastin)FDA Link
01/2020 - 12/2007
13Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 08/2004
11Hormones (Hormone)IBA
03/2021 - 02/2013
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 12/2007
11NeopterinIBA
07/2017 - 07/2005
11Irinotecan (Camptosar)FDA LinkGeneric
06/2015 - 07/2002
11Fluorouracil (Carac)FDA LinkGeneric
09/2014 - 07/2002
9Tyrosine Kinase InhibitorsIBA
02/2022 - 01/2011
9Biological ProductsIBA
03/2021 - 01/2014
9Trastuzumab (Herceptin)FDA Link
03/2021 - 09/2012
9Pharmaceutical PreparationsIBA
03/2018 - 01/2012
8Axitinib (AG 013736)IBA
10/2022 - 11/2013
8pembrolizumabIBA
10/2022 - 01/2019
8NivolumabIBA
04/2022 - 04/2018
8EverolimusFDA Link
01/2021 - 08/2013
8Aromatase InhibitorsIBA
08/2016 - 08/2009
8Vitamin A (Retinol)FDA LinkGeneric
04/2012 - 11/2006
7LipidsIBA
10/2022 - 01/2015
7Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2017 - 11/2005
7Leucovorin (Folinic Acid)FDA Link
09/2014 - 07/2002
7alpha-TocopherolFDA Link
04/2012 - 11/2007
6IpilimumabIBA
02/2022 - 11/2015
6Estrogen ReceptorsIBA
03/2021 - 06/2013
6Cetuximab (Erbitux)FDA Link
01/2021 - 04/2007
6GemcitabineFDA Link
01/2021 - 04/2003
6PlatinumIBA
01/2021 - 08/2004
6Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2006
5pazopanibFDA Link
02/2022 - 12/2017
5ErbB Receptors (EGF Receptor)IBA
03/2021 - 11/2008
5Capecitabine (Xeloda)FDA Link
12/2017 - 01/2012
5exemestane (Aromasin)FDA Link
08/2016 - 06/2013
5Mannitol (Osmitrol)FDA LinkGeneric
11/2014 - 08/2007
5Xylose (D-Xylose)FDA Link
11/2014 - 10/2005
5Lactulose (Duphalac)FDA LinkGeneric
11/2014 - 08/2007
4Carboplatin (JM8)FDA LinkGeneric
01/2022 - 11/2007
4Cytotoxins (Cytolysins)IBA
01/2020 - 06/2012
4Imatinib Mesylate (Gleevec)FDA Link
01/2019 - 11/2005
4Monoclonal AntibodiesIBA
12/2018 - 08/2006
4Sorafenib (BAY 43-9006)FDA Link
12/2017 - 12/2012
4Cisplatin (Platino)FDA LinkGeneric
09/2010 - 07/2002
3Immune Checkpoint InhibitorsIBA
02/2022 - 01/2021
3Alanine Transaminase (SGPT)IBA
02/2022 - 10/2019
3Docetaxel (Taxotere)FDA Link
10/2021 - 12/2019
3cabazitaxelFDA Link
10/2021 - 12/2019
3enzalutamideIBA
10/2021 - 12/2019
3abirateroneIBA
10/2021 - 12/2019
3MTOR InhibitorsIBA
09/2021 - 03/2014
3lenvatinibIBA
01/2021 - 11/2015
3Progesterone Receptors (Progesterone Receptor)IBA
12/2017 - 02/2008
3RamucirumabIBA
12/2017 - 01/2014
3CytokinesIBA
05/2014 - 09/2003
3Epidermal Growth Factor (EGF)IBA
02/2014 - 01/2012
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2012 - 07/2008
3Interleukin-2 (IL2)IBA
01/2009 - 10/2002
3Indicators and Reagents (Reagents)IBA
07/2008 - 07/2005
2cabozantinibIBA
03/2022 - 10/2020
2S-1,2-dichlorovinyl-N-acetylcysteineIBA
01/2022 - 01/2021
2EnzymesIBA
01/2022 - 03/2018

Therapy/Procedure

79Therapeutics
10/2022 - 07/2002
43Drug Therapy (Chemotherapy)
04/2022 - 07/2002
11Radiotherapy
05/2022 - 08/2004
11Neoadjuvant Therapy
01/2021 - 12/2008
9Immunotherapy
01/2022 - 07/2002
8Nephrectomy
02/2022 - 05/2010
6Combination Drug Therapy (Combination Chemotherapy)
06/2012 - 08/2004
4Chemoradiotherapy
01/2017 - 11/2006
3Castration
10/2021 - 12/2019
3Cytoreduction Surgical Procedures
09/2020 - 12/2018
3Hyperthermic Intraperitoneal Chemotherapy
09/2020 - 12/2018
3Brachytherapy
09/2006 - 07/2002